|
1
|
Chen YJ, Lin SC, Kao T, et al: Genome-wide
profiling of oral squamous cell carcinoma. J Pathol. 204:326–332.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pentenero M, Gandolfo S and Carrozzo M:
Importance of tumor thickness and depth of invasion in nodal
involvement and prognosis of oral squamous cell carcinoma: a review
of the literature. Head Neck. 27:1080–1091. 2005. View Article : Google Scholar
|
|
3
|
Myers JN, Elkins T, Roberts D and Byers
RM: Squamous cell carcinoma of the tongue in young adults:
increasing incidence and factors that predict treatment outcomes.
Otolaryngol Head Neck Surg. 122:44–51. 2000. View Article : Google Scholar
|
|
4
|
Motokura T, Bloom T, Kim HG, Jüppner H,
Ruderman JV, Kronenberg HM and Arnold A: A novel cyclin encoded by
a bcl1-linked candidate oncogene. Nature. 350:512–515. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bellacosa A, Almadori G, Cavallos S, et
al: Cyclin D1 gene amplification in human laryngeal squamous cell
carcinomas: prognostic significance and clinical implications. Clin
Cancer Res. 2:175–180. 1996.
|
|
6
|
Michalides R, van Veelen N, Hart A, Loftus
B, Wientjens E and Balm A: Overexpression of cyclin D1 correlates
with recurrence in a group of forty-seven operable squamous cell
carcinomas of the head and neck. Cancer Res. 55:975–978.
1995.PubMed/NCBI
|
|
7
|
Vora HH, Shah NG, Trivedi TT, et al:
Cyclin D1 expression in prediction of survival in carcinoma of the
tongue. GCRI Bulletin. 7:130–135. 1997.
|
|
8
|
Mishra R and Das BR: Cyclin D1 expression
and its possible regulation in chewing tobacco mediated oral
squamous cell carcinoma progression. Arch Oral Biol. 54:917–923.
2009. View Article : Google Scholar
|
|
9
|
Santarius T, Shipley J, Brewer D, Stratton
MR and Cooper CS: A census of amplified and overexpressed human
cancer genes. Nat Rev Cancer. 10:59–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: a changing paradigm. Nature Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bienvenu F, Jirawatnotai S, Elias JE, et
al: Transcriptional role of cyclin D1 in development revealed by a
genetic-proteomic screen. Nature. 463:374–378. 2010. View Article : Google Scholar
|
|
12
|
Carlos de Vicente J, Herrero-Zapatero A,
Fresno MF and López-Arranz JS: Expression of cyclin D1 and Ki-67 in
squamous cell carcinoma of the oral cavity: clinicopathological and
prognostic significance. Oral Oncol. 38:301–308. 2002.PubMed/NCBI
|
|
13
|
Sobin LH and Wittekind C: International
Union Against Cancer: TNM Classification of Malignant Tumors. 5th
edition. Wiley-Liss Publications; New York, NY: 1997
|
|
14
|
Wang L, Liu T, Nishioka M, Aguirre RL, Win
SS and Okada N: Activation of ERK1/2 and cyclin D1 expression in
oral tongue squamous cell carcinomas: relationship between
clinicopathological appearances and cell proliferation. Oral Oncol.
42:625–631. 2006. View Article : Google Scholar
|
|
15
|
Lam KY, Ng IO, Yuen AP, Kwong DL and Wei
W: Cyclin D1 expression in oral squamous cell carcinomas:
clinicopathological relevance and correlation with p53 expression.
J Oral Pathol Med. 29:167–172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Angadi PV and Krishnapillai R: Cyclin D1
expression in oral squamous cell carcinoma and verrucous carcinoma:
correlation with histological differentiation. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 103:e30–e35. 2007. View Article : Google Scholar
|
|
17
|
Bartkova J, Lukas J, Müller H, Strauss M,
Gusterson B and Bartek J: Abnormal patterns of D-type cyclin
expression and G1 regulation in human head and neck cancer. Cancer
Res. 55:949–956. 1995.PubMed/NCBI
|
|
18
|
Mikami T, Cheng J, Maruyama S, et al:
Emergence of keratin 17 vs. loss of keratin 13: their reciprocal
immunohistochemical profiles in oral carcinoma in situ. Oral Oncol.
47:497–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Musgrove EA, Lee CS, Buckley MF and
Sutherland RL: Cyclin D1 induction in breast cancer cells shortens
G1 and is sufficient for cells arrested in G1 to complete the cell
cycle. Proc Natl Acad Sci USA. 91:8022–8026. 1994. View Article : Google Scholar
|
|
20
|
Skapek SX, Rhee J, Spicer DB and Lasser
AB: Inhibition of myogenic differentiation in proliferating
myoblasts by cyclin D1-dependent kinase. Science. 267:1022–1024.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kotelnikov VM, Coon JS IV, Mundle S, et
al: Cyclin D1 expression in squamous cell carcinomas of the head
and neck and in oral mucosa in relation to proliferation and
apoptosis. Clin Cancer Res. 3:95–101. 1997.PubMed/NCBI
|
|
22
|
Lucibello FC, Sewing A, Brüsselbach S,
Bürger C and Müller R: Deregulation of cyclins D1 and E and
suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell
Sci. 105:123–133. 1993.PubMed/NCBI
|
|
23
|
Sauter ER, Nesbit M, Litwin S,
Klein-Szanto AJ, Cheffetz S and Herlyn M: Antisense cyclin D1
induces apoptosis and tumor shrinkage in human squamous carcinomas.
Cancer Res. 59:4876–4881. 1999.PubMed/NCBI
|
|
24
|
Li Z, Jiao X, Wang C, et al: Alternative
cyclin D1 splice forms differentially regulate the DNA damage
response. Cancer Res. 70:8802–8811. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Wang Q, Cui Y, et al: Knockdown of
cyclin D1 inhibits proliferation, induces apoptosis, and attenuates
the invasive capacity of human glioblastoma cells. J Neurooncol.
106:473–484. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Biliran H Jr, Wang Y, Banerjee S, et al:
Overexpression of cyclin D1 promotes tumor cell growth and confers
resistance to cisplatin-mediated apoptosis in an elastase-myc
transgene-expressing pancreatic tumor cell line. Clin Cancer Res.
11:6075–6086. 2005. View Article : Google Scholar
|
